Keywords = Daclatasvir
Number of Articles: 5
Impact of Treatment of Chronic HCV Patients by Direct Acting Antiviral Drugs (DAADs) on COVID -19 Disease Frequency and Severity

Volume 13, Issue 4, December 2023, Pages 225-239

Rasha H Shehata; Eman A Zareh; Ehab F Moustafa; Mariam Elkhyat; Nahed A Makhlof

Efficacy of Sofosbuvir and Ledipasvir in Comparison to Sofosbuvir and Daclatasvir in Management of Egyptian Chronic Hepatitis C Patients

Volume 10, Issue 2, June 2020, Pages 163-173

Israa Alaa Nouh; Adila Mostafa; Eman Elsheimy; Sameh Sief; Basem Eysa

Efficacy and Adverse Effects of Sofosbuvir plus Daclatasvir Therapy in Chronic HCV Patients in Sharkia Governorate, Egypt

Volume 8, Issue 4, December 2018, Pages 174-181

Nahla E El-Gammal; Noha E Shahin; Abeer Hussein abdelkader

Significance of screening antibodies to hepatitis B core antigen among chronic hepatitis C patients before antiviral therapy

Volume 8, Issue 4, December 2018, Pages 202-208

Mohamed Fathallah; Amany Moustafa; Mohamed Aboelmagd; Shyma Elkhodary; Mohammed Elhamouly

Afro-Egyptian Journal of Infectious and Endemic Diseases

Journal Archive